VRAX Stock IS Up 154%? Fosun Deal Leads July 9 Day Trading Watch List

Virax Biolabs more than doubled premarket on a new supply deal, the beaten down chip names are finally bouncing, and Ionis crashed 21 percent on a failed trial. Here is your day trading watch list for July 9.

Here is your premarket gapper watch list for Thursday, July 9, 2026, built for day trading. This market news roundup covers why the biggest premarket movers are gapping, from the Virax Biolabs (VRAX) supply deal to a semiconductor bounce in Micron (MU), Marvell (MRVL), Intel (INTC), and Broadcom (AVGO), plus the Ionis (IONS) trial failure. Every mover below comes straight from this morning's scan with volume, float, and daily ATR so you can see what is running before the open.

Two days of heavy selling in chips and AI names gave way to a bounce this morning. Micron, Broadcom, Intel, and Marvell are all green premarket as buyers stepped back into the AI hardware trade after Wall Street analysts called the pullback overdone. Bitcoin miners are also higher. On the downside, Ionis is the standout loser after a late stage trial setback. The tape has a risk on tone into the open, a clear shift from the pressure earlier in the week.

Virax Biolabs (VRAX) gapped up more than 150 percent premarket after its UK subsidiary signed an exclusive multi country commercial supply agreement with Fosun Diagnostics for its ImmuneSelect immune profiling product line. The deal covers six Southeast Asian markets, including Thailand, Vietnam, Indonesia, the Philippines, Singapore, and Malaysia, and sets up near term revenue. On a float of roughly 7 million shares, that news was enough to send VRAX to the top of the gapper list.

Ionis Pharmaceuticals (IONS) dropped about 21 percent premarket after its CARDIO-TTRansform Phase 3 trial for eplontersen failed to hit its goal in the ATTR-CM heart condition. That readout was a cornerstone of the 2026 growth story, so the miss removes a key pipeline catalyst and raises doubts about competing in a large market already led by a rival drug. The result erased months of gains and pulled the stock well below its recent high.

Micron (MU), Marvell (MRVL), Intel (INTC), SanDisk (SNDK), and Broadcom (AVGO) are all higher after two days of selling. UBS argued that Micron and Broadcom had gotten roughly 25 percent cheaper and are far from bubble territory, while Bank of America reiterated a Buy on Micron with a 1,550 dollar target, pointing to strong AI memory demand. Bitcoin miners MARA, WULF, and IREN are bouncing alongside the risk on move. This is a sector wide rebound, which is why so many chip and AI names show green on the scan below.